Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial publishing date : 2021 - 07 - 15 save search
INDUS Announces Agreement to Acquire an Industrial/Logistics Building
Published: 2021-07-15 (Crawled : 21:00) - globenewswire.com
INDT 4 | $66.99 0.02% 0.0% 0
|
Real Estate and Rental and Leas...
|
| O: -1.03%
H: 0.0%
C: 0.0%
trial
KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery Showed Statistically Significant Event-Free Survival (EFS) Result Versus Neoadjuvant Chemotherapy Alone in High-Risk Early-Stage TNBC
Published: 2021-07-15 (Crawled : 20:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M
|
Health Technology
|
| O: 0.0%
H: 0.54%
C: 0.36%
risk therapy keytruda
Global Superconducting Wire Markets, 2020-2027 - Growth Opportunities in Medical, Electronics & Communication, Industrial Processing and Research
Published: 2021-07-15 (Crawled : 19:00) - prnewswire.com
BRKR | $77.725 -1.06% -1.07% 1.3M
|
Health Technology
|
| O: -0.13%
H: 0.76%
C: -1.19%
AMSC 4 | $11.64 -0.94% -0.95% 320K
|
Producer Manufacturing
|
| O: 1.98%
H: 0.0%
C: -7.44%
electronics communication growth research trial
Lilly and Banner Alzheimer's Institute collaborate on planned Phase 3 prevention trial of donanemab
Published: 2021-07-15 (Crawled : 14:15) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.57%
H: 0.42%
C: -1.51%
alzheimer phase 3 trial collaboration alzheimer’s alzheimer's
Prometheus Biosciences to Host Virtual R&D Day for Investors on July 28, 2021Featuring management and expert-led discussions on the science of TL1A, including the application and clinical trial approach of PRA023 in Inflammatory Bowel Disease
Published: 2021-07-15 (Crawled : 14:15) - biospace.com/
RXDX | $199.92 0.02% 1.9M
|
Professional, Scientific, and T...
|
| O: 2.97%
H: 4.09%
C: -2.0%
disease trial
Bio-Thera Solutions Announces the First Patient Dosed in Phase III Clinical Trial for BAT2206, a Proposed Biosimilar of Stelara® (Ustekinumab)
Published: 2021-07-15 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.66%
H: 0.35%
C: -0.55%
trial biosimilar
Vir Biotechnology Initiates Phase 2 Clinical Trial Evaluating the Combination of VIR-2218 and VIR-3434 as a Functional Cure Regimen for Chronic Hepatitis B Virus Infection
Published: 2021-07-15 (Crawled : 14:00) - biospace.com/
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 0.08%
H: 2.71%
C: 2.31%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.16%
H: 1.35%
C: 1.11%
phase 2 hepatitis biotech technology iot trial injection infections chronic hepatitis b
Advaxis Announces Initiation of Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate CancerStudy in biochemically recurrent prostate cancer expands off-the-shelf ADXS-HOT program to second indication
Published: 2021-07-15 (Crawled : 14:00) - biospace.com/
ADXS | $0.57 12.48% 9.5K
|
Health Technology
|
| O: 1.07%
H: 3.16%
C: 0.79%
treatment prostate cancer phase 1 cancer trial
The CNH Industrial Foundation donates 250k to support Team Rubicon’s disaster response
Published: 2021-07-15 (Crawled : 14:00) - globenewswire.com
CNHI | $12.31 -0.73% 0.0% 6.9M
|
Producer Manufacturing
|
| O: -1.11%
H: 0.62%
C: -0.06%
trial response
Ballard Receives Order for Fuel Cell Modules to Power Trial Operation of Siemens Mireo Plus H Train
Published: 2021-07-15 (Crawled : 13:00) - prnewswire.com
BLDP | $2.64 -1.86% -1.89% 2.4M
|
Producer Manufacturing
|
| O: -0.78%
H: 2.61%
C: -0.85%
trial fuel cell order train
NLS Pharmaceutics Announces FDA Acceptance of IND Application to Initiate Clinical Trials with Quilience(R) (mazindol ER) to Treat Narcolepsy
Published: 2021-07-15 (Crawled : 13:00) - biospace.com/
NLSP | $0.1327 6.04% 74K
|
|
| O: 12.62%
H: 9.73%
C: -7.37%
fda fda acceptance clinical trials narcolepsy trial application
Advaxis Announces Initiation of Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer
Published: 2021-07-15 (Crawled : 12:15) - globenewswire.com
ADXS | $0.57 12.48% 9.5K
|
Health Technology
|
| O: 1.07%
H: 3.16%
C: 0.79%
treatment prostate cancer phase 1 cancer trial phase 2 phase 3
BioCryst Announces Designs for REDEEM-1 and REDEEM-2 Pivotal Trials with BCX9930 as Oral Monotherapy for Patients with PNH
Published: 2021-07-15 (Crawled : 12:00) - biospace.com/
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: -0.38%
H: 2.89%
C: 1.48%
therapy trial designation
Navidea Biopharmaceuticals Announces End-of-Phase 2 Type B Meeting Request Granted by the FDA to Discuss Ongoing Clinical Program in Rheumatoid Arthritis
Published: 2021-07-15 (Crawled : 12:00) - biospace.com/
NAVB | $0.035 50.69% 15K
|
Health Technology
|
| O: 8.29%
H: 0.0%
C: -7.14%
fda phase 2 biopharma rheumatoid arthritis ongoing
Compugen Doses First Patient in Phase 1 Combination Study of COM902 and COM701 in Patients with Advanced Malignancies
Published: 2021-07-15 (Crawled : 12:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: -3.94%
phase 1 phase 2 phase 3
CSW Industrials Declares Quarterly Dividend
Published: 2021-07-15 (Crawled : 12:00) - globenewswire.com
CSWI | $232.19 -0.77% -0.77% 150K
|
Process Industries
|
| O: -0.3%
H: 0.0%
C: -0.83%
trial
Theratechnologies Reports Financial Results for the Second Quarter of Fiscal 2021 and Provides Update on Its Planned Phase 3 Clinical Trial in NASH
Published: 2021-07-15 (Crawled : 11:00) - globenewswire.com
THTX | $1.29 -12.78% 8.1K
|
Health Technology
|
| O: -2.17%
H: 1.39%
C: -2.78%
financial results results phase 3 nash trial
Industrial Controls and Factory Automation Market growth analysis in Electrical Components & Equipment Industry | Technavio
Published: 2021-07-15 (Crawled : 04:00) - prnewswire.com
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: -0.62%
H: 0.76%
C: 0.28%
growth trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.